» Articles » PMID: 21274872

Autoimmune Acute Liver Failure: Proposed Clinical and Histological Criteria

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2011 Jan 29
PMID 21274872
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Identifying autoimmune hepatitis as the etiology of acute liver failure (ALF) is potentially important, because administering corticosteroids might avoid the need for liver transplantation. However, clinical and histological criteria of autoimmune ALF (AI-ALF) have not been defined. Liver sections (biopsies and explants) from a 72-patient subset of the ALF Study Group Registry with indeterminate ALF were reviewed by a pathologist blinded to all clinical data and were diagnosed with probable AI-ALF based on four features suggestive of an autoimmune pathogenesis: distinctive patterns of massive hepatic necrosis (present in 42% of sections), presence of lymphoid follicles (32%), a plasma cell-enriched inflammatory infiltrate (63%), and central perivenulitis (65%). Forty-two sections (58%) were considered probable for AI-ALF; this group demonstrated higher serum globulins (3.7 ± 0.2 g/dL versus 3.0 ± 0.2 g/dL; P = 0.037) and a higher prevalence of antinuclear and/or anti-smooth muscle antibodies (73% versus 48%; P = 0.034) compared to those without histology suggestive of probable AI-ALF. Thirty patients concordant for autoantibodies and probable AI-ALF upon histological analysis were more likely to have the classical autoimmune hepatitis phenotype (female predominance [72% versus 48%; P < 0.05], higher globulins [3.9 ± 0.2 g/dL versus 3.0 ± 0.2 g/dL; P < 0.005], and higher incidence of chronic hepatitis in long-term follow-up [67% versus 17%, P = 0.019]) compared to the population without concordant AI-ALF histology and autoantibodies.

Conclusion: Patients with indeterminate ALF often have features of autoimmune disease by histological analysis, serological testing, and clinical recurrence during follow-up. In contrast to classical autoimmune hepatitis, histological features of AI-ALF predominate in the centrilobular zone.

Citing Articles

Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia.

Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A Hepatol Int. 2025; 19(1):1-69.

PMID: 39961976 PMC: 11846769. DOI: 10.1007/s12072-024-10773-4.


autoimmune hepatitis? - Summary of the 5 international autoimmune hepatitis group research workshop 2024.

Engel B, Assis D, Bhat M, Clusmann J, Drenth J, Gerussi A JHEP Rep. 2025; 7(2):101265.

PMID: 39897612 PMC: 11783120. DOI: 10.1016/j.jhepr.2024.101265.


Hellenic Association for the Study of the Liver (HASL): revised clinical practice guidelines for autoimmune hepatitis.

Dalekos G, Papatheodoridis G, Koskinas J, Goulis I, Rigopoulou E, Tiniakos D Ann Gastroenterol. 2024; 37(6):623-654.

PMID: 39568707 PMC: 11574148. DOI: 10.20524/aog.2024.0924.


Liver fibrosis is closely linked with metabolic-associated diseases in patients with autoimmune hepatitis.

Liu K, Feng M, Chi W, Cao Z, Wang X, Ding Y Hepatol Int. 2024; 18(5):1528-1539.

PMID: 39249647 PMC: 11461548. DOI: 10.1007/s12072-024-10727-w.


Diagnosis and management of pediatric acute liver failure: consensus recommendations of the Indian Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ISPGHAN).

Lal B, Khanna R, Sood V, Alam S, Nagral A, Ravindranath A Hepatol Int. 2024; 18(5):1343-1381.

PMID: 39212863 DOI: 10.1007/s12072-024-10720-3.


References
1.
Leung P, Rossaro L, Davis P, Park O, Tanaka A, Kikuchi K . Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology. 2007; 46(5):1436-42. PMC: 3731127. DOI: 10.1002/hep.21828. View

2.
Abe M, Onji M, Kawai-Ninomiya K, Michitaka K, Matsuura B, Hiasa Y . Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis. Clin Gastroenterol Hepatol. 2007; 5(2):255-8. DOI: 10.1016/j.cgh.2006.10.011. View

3.
TREY C, Davidson C . The management of fulminant hepatic failure. Prog Liver Dis. 1970; 3:282-98. View

4.
Farci P, Diaz G, Chen Z, Govindarajan S, Tice A, Agulto L . B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure. Proc Natl Acad Sci U S A. 2010; 107(19):8766-71. PMC: 2889296. DOI: 10.1073/pnas.1003854107. View

5.
Soloway R, Summerskill W, BAGGENSTOSS A, GEALL M, Gitnick G, Elveback I . Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972; 63(5):820-33. View